Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

CSL hemophilia A drug approved in Japan

Global biotherapeutics leader CSL Behring announced that Japan’s Ministry of Health, Labor and Welfare approved Afstyla [lonoctocog alfa] for hemophilia A.

Read More »

AbbVie, Amgen resolve Humira patent disputes

AbbVie announced today a global resolution of all intellectual property-related litigation with Amgen over Amgen’s proposed biosimilar adalimumab product.

Read More »

Abiomed invests in Israeli medical device maker Magenta

Israeli medical device company Magenta Medical said it has raised $15 million in funding led by Massachusetts-based Abiomed Inc., a maker of catheter-based heart pumps, and venture capital firm Pitango.

Read More »

EDC Database Development Often Leads to Clinical Trial Delays, Study Shows

It has long been thought that electronic data collection, also known as EDC, would be a time-saver when it comes to running clinical trials. But that may not be the case, according to a joint study released by Tufts University and Veeva Systems.

Read More »

EU approves Sanofi and Regeneron’s dupilumab in eczema

The European Commission approved Regeneron Pharmaceuticals’ and Sanofi’s key biologic treatment dupilumab for moderate-to-severe atopic dermatitis, the two companies said.

Read More »

Novartis forges UC Berkeley pact, sees drug hopefuls in three years

Novartis’ research head expects an alliance with a University of California chemistry lab to produce drug candidates within three years as the Swiss company accelerates its hunt for new medicines.

Read More »

Mateon Therapeutics Cuts 60 Percent of Jobs

Following a failure to determine clear efficacy in its experimental combo ovarian cancer drug, Mateon ended the drug program and cut 60% of its employees.

Read More »

Ex-Biotech Analyst Charged With Insider Trading

The U.S. Attorney’s Office in Chicago charged a former Zacks biotech analyst with securities fraud over allegations of insider trading.

Read More »

EU drugs watchdog staff favor move to Amsterdam: sources

Picking Amsterdam, Barcelona or Vienna as the new headquarters of Europe’s drugs regulator after Brexit would be the best option for retaining staff, according to a survey of its workers.

Read More »

Republicans fail again to kill off Obamacare in Senate

U.S. Republicans fell short yet again in their seven-year drive to repeal Obamacare, in a bitter defeat that raises more questions about their ability to enact President Donald Trump’s agenda.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom